Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Gubra
Gubra
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Gubra
Revenue
KR2.6 B
FY, 2025
Gubra Summary
Company Summary
Overview
Gubra is a biotech company that provides drug discovery programs and pre-clinical contract research services. It specializes in peptide chemistry, in vivo pharmacology, 3D imaging, molecular pharmacology, stereology, bioinformatics, etc.
Type
Public
Status
Active
Founded
2008
HQ
Hørsholm, DK
|
view all locations
Website
https://www.gubra.dk
Cybersecurity rating
Sectors
Healthcare
biotech
clinical research
drug development
pharma
Homepage
Linkedin
youtube
twitter
Table of Contents
Key People
Operating Metrics
Locations
Financials
Competitors
Key People
Henrik Blou,
Chief Executive Officer
Linkedin
Niels Vrang,
Co-Founder, Chief Science Officer
Linkedin
Kristian Borbos,
Chief Financial Officer
Linkedin
Trine Nygaard Hamann,
Chief Business Officer
Linkedin
and 4 others
Operating Metrics
View all
Customers
101
7.4%
FY, 2022
Products in Development
14
FY, 2022
Locations
View all
1 location detected
Hørsholm
HQ
Denmark
Hørsholm Kongevej 11B
Gubra Financials
Summary Financials
Revenue (FY, 2025)
kr2.6B
Gross profit (FY, 2025)
kr2.6B
Net income (FY, 2025)
kr1.7B
Cash (FY, 2025)
kr32.2M
EBIT (FY, 2025)
kr2.2B
Competitors and Similar Companies
CerSci Therapeutics
Healthcare - Subsidiary
Ncardia
Healthcare - Private
CNS Healthcare
Healthcare - Private
Tergus Pharma
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top